Similar Articles
The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
Rabia Gökçen Gözübatık Çelik, Musa Öztürk, Serap Altın, Mesrure Köseoğlu, Hande Sariahmetoğlu, Mesude Tütüncü, Aysun Soysal
DOI: 10.4274/tnd.2019.04207
Issue: 2019, Volume 25 - Issue 3
0
317
The Effect of Ocrelizumab in the Treatment of Multipl Sclerosis
Şenay Yıldız Çelik
DOI: 10.4274/tnd.71354
Issue: 2017, Volume 23 - Issue 3
0
238